Literature DB >> 23853557

Serum brain-derived neurotrophic factor levels are associated with dyssomnia in females, but not males, among Japanese workers.

Reiko Nishichi1, Yu Nufuji, Masakazu Washio, Shuzo Kumagai.   

Abstract

STUDY
OBJECTIVES: Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family of growth factors that promote the growth and survival of neurons. Recent evidence suggests that BDNF is a sleep regulatory substance that contributes to sleep behavior. However, no studies have examined the association between the serum BDNF levels and dyssomnia. The present study was conducted to clarify the association between the serum BDNF levels and dyssomnia.
METHODS: A total of 344 workers (age: 40.1 ± 10.5 years, male: 204, female: 140) were included in the study. The serum BDNF levels were categorized into tertiles according to sex.
RESULTS: The prevalence of dyssomnia was 35.1% in males and 30.0% in females. In the females, the BDNF levels were found to be negatively associated with dyssomnia after adjusting for age, body mass index, hypertension, dyslipidemia, hyperglycemia, depression, smoking, alcohol intake, and regular exercise. Compared with the females in the high BDNF group, the multivariate odds ratio (95% CI) of dyssomnia was 2.08 (0.62-6.98) in females in the moderate BDNF group and 8.41 (2.05-27.14) in females in the low BDNF group. No such relationships were found in the males.
CONCLUSIONS: The serum BDNF levels are associated with dyssomnia in Japanese female, but not male, workers.

Entities:  

Keywords:  Japanese worker; Serum brain-derived neurotrophic factor; dyssomnia; sex

Mesh:

Substances:

Year:  2013        PMID: 23853557      PMCID: PMC3671328          DOI: 10.5664/jcsm.2828

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  38 in total

1.  Effect of combined cardiovascular risk factors on individual and population medical expenditures: a 10-year cohort study of national health insurance in a Japanese population.

Authors:  Tomonori Okamura; Koshi Nakamura; Hideyuki Kanda; Takehito Hayakawa; Atsushi Hozawa; Yoshitaka Murakami; Takashi Kadowaki; Yoshikuni Kita; Akira Okayama; Hirotsugu Ueshima
Journal:  Circ J       Date:  2007-06       Impact factor: 2.993

2.  Brain-derived neurotrophic factor antisense oligonucleotide impairs memory retention and inhibits long-term potentiation in rats.

Authors:  Y L Ma; H L Wang; H C Wu; C L Wei; E H Lee
Journal:  Neuroscience       Date:  1998-02       Impact factor: 3.590

3.  Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus.

Authors:  Masataka Suwa; Hiroyo Kishimoto; Yu Nofuji; Hiroshi Nakano; Haruka Sasaki; Zsolt Radak; Shuzo Kumagai
Journal:  Metabolism       Date:  2006-07       Impact factor: 8.694

4.  Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor.

Authors:  Baoji Xu; Evan H Goulding; Keling Zang; David Cepoi; Roger D Cone; Kevin R Jones; Laurence H Tecott; Louis F Reichardt
Journal:  Nat Neurosci       Date:  2003-07       Impact factor: 24.884

5.  Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease.

Authors:  M Narisawa-Saito; K Wakabayashi; S Tsuji; H Takahashi; H Nawa
Journal:  Neuroreport       Date:  1996-11-25       Impact factor: 1.837

6.  Diabetes and sleep disturbances: findings from the Sleep Heart Health Study.

Authors:  Helaine E Resnick; Susan Redline; Eyal Shahar; Adele Gilpin; Anne Newman; Robert Walter; Gordon A Ewy; Barbara V Howard; Naresh M Punjabi
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

7.  Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years.

Authors:  Robert Stewart; Alain Besset; Paul Bebbington; Traolach Brugha; James Lindesay; Rachel Jenkins; Nicola Singleton; Howard Meltzer
Journal:  Sleep       Date:  2006-11       Impact factor: 5.849

8.  Morbidity associated with sleep disorders in primary care: a longitudinal cohort study.

Authors:  Mari-Ann Wallander; Saga Johansson; Ana Ruigómez; Luis A García Rodríguez; Roger Jones
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

9.  Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity.

Authors:  Palmiero Monteleone; Alfonso Tortorella; Vassilis Martiadis; Cristina Serritella; Antonio Fuschino; Mario Maj
Journal:  Psychosom Med       Date:  2004 Sep-Oct       Impact factor: 4.312

10.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

View more
  5 in total

Review 1.  The Brain-Derived Neurotrophic Factor: Missing Link Between Sleep Deprivation, Insomnia, and Depression.

Authors:  Maryam Rahmani; Farzaneh Rahmani; Nima Rezaei
Journal:  Neurochem Res       Date:  2019-11-28       Impact factor: 3.996

2.  Association of sleep duration and sleep quality with hypertension in oil workers in Xinjiang.

Authors:  Fen Yang; Yuanyue Zhang; Ruiying Qiu; Ning Tao
Journal:  PeerJ       Date:  2021-05-03       Impact factor: 2.984

3.  Association of serum BDNF levels and the BDNF Val66Met polymorphism with the sleep pattern in healthy young adults.

Authors:  Kaori Saitoh; Ryuji Furihata; Yoshiyuki Kaneko; Masahiro Suzuki; Sakae Takahashi; Makoto Uchiyama
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240

4.  Association of Sleep, Body Weight and Physical Exercise with Plasma BDNF Levels in Healthy Male Saudi Smokers.

Authors:  Arwa Al-Mshari; Mona Hmoud AlSheikh; Rabia Latif; Sadaf Mumtaz; Waleed Albaker; Mohammed Al-Hariri
Journal:  Int J Gen Med       Date:  2022-08-17

Review 5.  Sleep, Health and Wellness at Work: A Scoping Review.

Authors:  Nicola Magnavita; Sergio Garbarino
Journal:  Int J Environ Res Public Health       Date:  2017-11-06       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.